What does MACE stand for in cardiovascular risk assessment?

What does MACE stand for in cardiovascular risk assessment?

• A. Major Adverse Cardiovascular Events
• B. Major Acute Coronary Event
• C. Myocardial Adverse Cerebral Events
• D. Mortality and Cardiovascular Events

Answer: (A)

MACE is a composite endpoint used in cardiovascular research to capture the most clinically important events that signal a poor cardiovascular prognosis. The standard phrase is Major Adverse Cardiovascular Events, and this is why it’s the best answer: it reflects a broad, clinically meaningful set of outcomes that trials and risk assessments track together, rather than focusing on a single event. In practice, MACE commonly includes death from cardiovascular causes, nonfatal myocardial infarction, and nonfatal stroke. Some definitions also add events like urgent revascularization or heart failure hospitalization, depending on the study. The other options misname or narrow the concept: “Major Acute Coronary Event” suggests only coronary issues and misses other major cardiovascular consequences; “Myocardial Adverse Cerebral Events” mixes terminology in a nonstandard way; “Mortality and Cardiovascular Events” isn’t the established acronym used in trials and risk assessment.

MACE is a composite endpoint used in cardiovascular research to capture the most clinically important events that signal a poor cardiovascular prognosis. The standard phrase is Major Adverse Cardiovascular Events, and this is why it’s the best answer: it reflects a broad, clinically meaningful set of outcomes that trials and risk assessments track together, rather than focusing on a single event.

In practice, MACE commonly includes death from cardiovascular causes, nonfatal myocardial infarction, and nonfatal stroke. Some definitions also add events like urgent revascularization or heart failure hospitalization, depending on the study. The other options misname or narrow the concept: “Major Acute Coronary Event” suggests only coronary issues and misses other major cardiovascular consequences; “Myocardial Adverse Cerebral Events” mixes terminology in a nonstandard way; “Mortality and Cardiovascular Events” isn’t the established acronym used in trials and risk assessment.